Actively Recruiting

Phase 3
Age: 45Years - 75Years
All Genders
NCT06944522

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Led by BlueRock Therapeutics · Updated on 2026-05-01

102

Participants Needed

39

Research Sites

349 weeks

Total Duration

On this page

Sponsors

B

BlueRock Therapeutics

Lead Sponsor

B

Bayer

Collaborating Sponsor

AI-Summary

What this Trial Is About

Study BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of bemdaneprocel in approximately 102 adults with Parkinson's Disease (PD).

CONDITIONS

Official Title

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Who Can Participate

Age: 45Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of clinically established Parkinson's Disease as defined by the International Parkinson and Movement Disorders Society
  • Male or female aged between 45 and 75 years at informed consent
  • Clear and strong response to dopaminergic therapy as shown by MDS-UPDRS Part III
  • Parkinson's Disease diagnosis between 4 and less than 12 years before informed consent
  • Must respond to levodopa therapy
  • Currently receiving medical treatment for Parkinson's Disease symptoms
  • Experiencing at least 2.5 hours of daily OFF-time
  • Vaccinated according to current national guidelines or local practice for patients with altered immune systems
Not Eligible

You will not qualify if you...

  • Parkinson's Disease with recurrent falls
  • Diagnosis of primary mitochondrial disorder, epilepsy, stroke, multiple sclerosis, or neurodegenerative diseases other than Parkinson's Disease (including multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, or Lewy body dementia)
  • Serious, severe, or unstable physical, neurological, or psychiatric illness that could affect participation or safety
  • History of gene therapy or cell therapy
  • Prior treatment with intrajejunal or subcutaneous infusion therapies for Parkinson's Disease
  • Previous brain surgery or radiation therapy, including deep brain stimulation or lesion therapy, or intradural spinal cord surgery
  • Contraindications to surgery, anesthesia, cell therapy, immunosuppression, or imaging procedures (PET or MRI)
  • Active infections such as HIV, HCV, HBV, CMV, syphilis, or tuberculosis, or conditions that increase risk from immunosuppression
  • Current or recent malignant disease within the past 5 years
  • Chronic immunosuppressive therapy
  • Use of another investigational therapy within 5 half-lives of active treatment
  • Pregnancy or breastfeeding

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 39 locations

1

Banner Sun Health Research Institute

Sun City, Arizona, United States, 85351

Actively Recruiting

2

University of Arkansas for Medical Sciences

Little Rock, Arkansas, United States, 72205

Actively Recruiting

3

UCLA NeuroTranslational Research Center

Los Angeles, California, United States, 90095

Actively Recruiting

4

UCI Medical Center - Neurology

Orange, California, United States, 92868

Actively Recruiting

5

University of Colorado Hospital - Neurology Clinic

Aurora, Colorado, United States, 80045

Actively Recruiting

6

MedStar Georgetown University Hospital

Washington D.C., District of Columbia, United States, 20007

Actively Recruiting

7

University of Miami Health System - Neurology

Miami, Florida, United States, 33136

Actively Recruiting

8

USF Parkinson's Disease and Movement Disorders Center

Tampa, Florida, United States, 33613

Actively Recruiting

9

Parkinson's Disease and Movement Disorders Center at Northwestern Memorial Hospital

Chicago, Illinois, United States, 60611

Actively Recruiting

10

University of Kansas Medical Center

Kansas City, Kansas, United States, 66160-8500

Actively Recruiting

11

University of Louisville Hospital

Louisville, Kentucky, United States, 40202

Actively Recruiting

12

Johns Hopkins Hospital - Neurology

Baltimore, Maryland, United States, 21287

Actively Recruiting

13

Tufts Medical Center - Neurology

Boston, Massachusetts, United States, 02111

Actively Recruiting

14

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

Actively Recruiting

15

Michigan Clinical Research Unit - Neurology

Ann Arbor, Michigan, United States, 48109

Actively Recruiting

16

University of Michigan Clinical Research Unit - Neurology

Ann Arbor, Michigan, United States, 48109

Actively Recruiting

17

Quest Research Institute

Farmington Hills, Michigan, United States, 48334

Actively Recruiting

18

UBMD Neurology

Buffalo, New York, United States, 14221

Actively Recruiting

19

Mount Sinai West - Neurology

New York, New York, United States, 10019

Actively Recruiting

20

New York Presbyterian/Weill Cornell Medical Center

New York, New York, United States, 10065

Actively Recruiting

21

Duke Neurological Disorders Clinic

Durham, North Carolina, United States, 27710

Actively Recruiting

22

University of Toledo Medical Center

Toledo, Ohio, United States, 43614

Actively Recruiting

23

OHSU Neurology Clinic, South Waterfront

Portland, Oregon, United States, 97239

Actively Recruiting

24

Rhode Island Hospital - Neurology

Providence, Rhode Island, United States, 02903

Actively Recruiting

25

Medical University of South Carolina, Movement Disorders Dept.

Charleston, South Carolina, United States, 29425

Actively Recruiting

26

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37232

Actively Recruiting

27

UTHealth Houston Neurosciences - Texas Medical Center

Houston, Texas, United States, 77030

Actively Recruiting

28

University of Vermont Medical Center

Burlington, Vermont, United States, 05401

Actively Recruiting

29

Virginia Commonwealth University

Richmond, Virginia, United States, 23284

Actively Recruiting

30

EvergreenHealth - Research Department

Kirkland, Washington, United States, 98034

Actively Recruiting

31

NeuRA (Neuroscience Research Australia)

Randwick, New South Wales, Australia, 2031

Actively Recruiting

32

Gold Coast Hospital & Health Service

Southport, Queensland, Australia, 4215

Actively Recruiting

33

Princess Alexandra Hospital

Woolloongabba, Queensland, Australia, 4102

Actively Recruiting

34

Monash Medical Centre

Clayton, Victoria, Australia, 3168

Actively Recruiting

35

The Alfred Hospital

Melbourne, Victoria, Australia, 3004

Actively Recruiting

36

The Royal Melbourne Hospital

Parkville, Victoria, Australia, 3050

Actively Recruiting

37

The University of British Columbia

Vancouver, British Columbia, Canada, V6T 1Z3

Actively Recruiting

38

University Health Network - Toronto Western Hospital

Toronto, Ontario, Canada, M5T 2S8

Actively Recruiting

39

CHUM - Centre hospitalier de l'Université de Montréal

Montreal, Quebec, Canada, H2X 0C1

Actively Recruiting

Loading map...

Research Team

P

Patient Engagement

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here